Tci Wealth Advisors, Inc. Novo Cure LTD Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$56.44 - $118.81 $338 - $712	-6 Reduced 21.43%	22 $1,000
Q3 2022 Nov 08, 2022	BUY	$67.99 - $89.57 $407 - $537	6 Added 27.27%	28 $2,000
Q2 2022 Jul 19, 2022	SELL	$56.6 - $89.9 $452 - $719	-8 Reduced 26.67%	22 $2,000
Q1 2022 Apr 29, 2022	SELL	$60.15 - $84.52 $4,390 - $6,169	-73 Reduced 70.87%	30 $3,000
Q4 2021 Jan 24, 2022	BUY	$75.08 - $121.99 $7,658 - $12,442	102 Added 10200.0%	103 $8,000
Q3 2021 Oct 29, 2021	SELL	$116.17 - $194.55 $5,692 - $9,532	-49 Reduced 98.0%	1 $0
Q2 2021 Aug 02, 2021	BUY	$130.4 - $225.58 $4,303 - $7,444	33 Added 194.12%	50 $11,000
Q1 2021 Apr 29, 2021	BUY	$124.11 - $190.17 $2,109 - $3,232	17 New	17 $2,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.